This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tohoku University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Hideo Higuchi: Innovator in Cancer Research
Introduction
Hideo Higuchi is a prominent inventor based in Sendai, Japan. He has made significant contributions to the field of cancer research, particularly in the development of therapies aimed at inhibiting cancer cell migration and invasion.
Latest Patents
Higuchi holds a patent for a cancer cell migration and cancer cell invasion inhibitor. This patent provides an antibody that specifically binds to PAR1 (protease activated receptor 1) or a fragment of the antibody that retains similar characteristics. The composition is designed to inhibit the migration and invasion activities of cancer cells, offering a potential medicinal composition for treating cancer and related conditions.
Career Highlights
Hideo Higuchi is affiliated with Tohoku University, where he conducts his research and development work. His innovative approach to cancer treatment has garnered attention in the scientific community.
Collaborations
Higuchi has collaborated with notable colleagues, including Kohsuke Gonda and Noriaki Ohuchi, to advance research in cancer therapies.
Conclusion
Hideo Higuchi's work in cancer research exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new treatments that could significantly improve patient outcomes.